搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
22 小时
GSK就mRNA专利权起诉Moderna
该诉讼声称,Moderna用于将mRNA传递到细胞中的脂质纳米粒子侵犯了GSK的专利。根据GSK的说法,这些专利是Moderna疫苗产品所使用的mRNA技术的基础。GSK此前曾在同一法院对辉瑞制药公司和BioNTech提起类似诉讼,针对的是他们联合开发的COVID-19疫苗。
大众网
2 小时
葛兰素史克(GSK.US)称RSV疫苗保护作用可持续三个季度
智通财经APP获悉,葛兰素史克 (GSK.US)周二表示,其呼吸道合胞病毒 (RSV)疫苗在接种后的三个季度都具有保护作用。经季节性因素调整后的数据显示,这种用于老年人的疫苗的三个季度累积有效性为62.9%。
18 小时
GSK sues Moderna for US patent infringement over COVID, RSV vaccines
British drugmaker GlaxoSmithKline sued Moderna in U.S. federal court in Delaware on Tuesday, accusing its American rival of ...
Axios on MSN
4 小时
GSK sues Moderna over mRNA vaccine technology
GlaxoSmithKline is suing Moderna for allegedly using technology patented by GSK in its COVID-19 vaccine. Why it matters: It's ...
BioSpace
1 小时
GSK Sues Moderna for Alleged Patent Infringement on COVID-19, RSV Vaccines
The lawsuits claim that Moderna used and profited from crucial mRNA technology in its COVID-19 vaccine Spikevax and ...
The Pharma Letter
3 小时
GSK files lawsuit against Moderna
UK pharma major GSK has sued USA-based Moderna this week, accusing the latter of violating patents protecting GSK’s COVID-19 ...
pharmaphorum
7 小时
GSK turns its guns on Moderna in mRNA jab patent dispute
The Mandl team was originally employed by Novartis, but GSK acquired rights to their work and intellectual property when it acquired Novartis' global vaccine business in 2015. Only by tapping into ...
Daily
4 小时
GSK alleges patent infringement by Moderna in development of COVID19, RSV vaccines, files ...
London: British drugmaker GlaxoSmithKline (GSK) sued Moderna in U.S. federal court in Delaware on Tuesday, accusing its ...
devdiscourse
15 小时
Patent Wars: GSK Takes on Moderna Over mRNA Innovations
GlaxoSmithKline has filed lawsuits against Moderna in a Delaware federal court, alleging infringement of patents related to ...
The Express Tribune
17 小时
GSK sues Moderna over US patent violation of Spikevax COVID-19 vaccine
A Moderna spokesperson said the company was aware of the new litigation and would defend itself against the claims ...
中华网
4 天
辉瑞终止口服RSV疗法开发!聚焦RSV疫苗,与GSK杠上了?
近日,辉瑞宣布终止针对呼吸道合胞病毒(RSV)治疗药物sisunatovir的开发。根据10月7日ClinicalTrials.gov网站的更新,辉瑞已经停止了两项关于sisunatovir治疗RSV感染的临床研究。
devdiscourse
1 小时
Top Health Headlines: From Legal Battles to Breakthroughs
Abbott's optimistic forecasts due to high sales of glucose monitors; legal issues with Moderna and GSK; J&J's talc case ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈